Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients

Title
Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients
Authors
Keywords
COVID-19, HbA1c, Diabetes, Inflammation, Prognosis
Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 164, Issue -, Pages 108214
Publisher
Elsevier BV
Online
2020-05-19
DOI
10.1016/j.diabres.2020.108214

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started